Cardiocast

AHA drills into CV risk factors in children

Publish date: February 28, 2019

 

A weight-loss drug is poised for expanded indication, the FDA says a popular gout drug raises cardiovascular risk, an AHA statement targets CV risk factors in children, and a class action suit against the American Board of Internal Medicine over MOC gets financial support from doctors.

Amazon AlexaApple Podcasts

Google Podcasts

TuneIn

Recommended Reading

Elevated CAC not linked to increased death risk in physically active men
MDedge Family Medicine
Statins cut vascular events in elderly patients
MDedge Family Medicine
‘Simple’ way to cut PAD risk, misguided ED visits for atrial fib, and more
MDedge Family Medicine
SGLT2 inhibitors morph into HF drugs
MDedge Family Medicine
Statin adherence lower in women, minorities
MDedge Family Medicine
Hormone therapy in transgender individuals may up risk of CV events
MDedge Family Medicine
Who is least adherent to statins, and more
MDedge Family Medicine
AHA: Consider obesity as CVD risk factor in children
MDedge Family Medicine
FDA accepts supplemental New Drug Application to expand lorcaserin label
MDedge Family Medicine
FDA approves label extension for dapagliflozin
MDedge Family Medicine